BioRestorative Therapies (BRTX) Ending Cash Balance (2010 - 2026)
BioRestorative Therapies (BRTX) reported Ending Cash Balance of $3.11 million for Q1 2026, up 153.3% from $1.23 million a year earlier and up 106.0% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Ending Cash Balance (2010 - 2026) Analysis & Trends
For FY2025, BioRestorative Therapies posted Ending Cash Balance of $1.51 million, up 175.8% from FY2024.
- Ending Cash Balance has a five-year compound annual growth rate of -13.2% (FY2020 to FY2025).
- By year, Ending Cash Balance came in at $547,890 in FY2024 (-38.0%), $884,377 in FY2023 (-48.4%), $1.71 million in FY2022 (-91.8%) and $21.03 million in FY2021 (+586.1%).
- The Q1 2026 figure ranks as the highest quarterly Ending Cash Balance since Q3 2022.
- Year over year, Ending Cash Balance gained in four of the last eight quarters, with growth averaging 24.3%.
- The high point for year-over-year Ending Cash Balance in five years was Q2 2022 (growth of 919.5%); the low point was Q4 2022 (a decline of 91.8%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $1.51 million (Q4 2025), $602,444 (Q3 2025) and $1.56 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | 3.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.11 Mn |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 602,444.00 |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 547,890.00 |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 2.25 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 884,377.00 |
| Sep 30, 2023 | 2.44 Mn |
| Jun 30, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 6.57 Mn |
| Jun 30, 2022 | 17.93 Mn |
| Mar 31, 2022 | 19.32 Mn |
| Dec 31, 2021 | 21.03 Mn |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 1.76 Mn |
API Access
BioRestorative Therapies Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();